Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-09-17

FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Original Application (Marlex Pharmaceuticals Inc)

View source ↗

Summary

FDA approved levocetirizine dihydrochloride under an original application for a generic antihistamine indicated for relief of symptoms of allergic rhinitis and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levocetirizine dihydrochloride (LEVOCETIRIZINE DIHYDROCHLORIDE)

Snippet

ORIG AP for LEVOCETIRIZINE DIHYDROCHLORIDE (LEVOCETIRIZINE DIHYDROCHLORIDE)